|
|
| | 8-BroMo-3,7-dihydro-3-Methyl-7-(phenylMethyl)-1H-purine-2,6-dione Basic information |
| Product Name: | 8-BroMo-3,7-dihydro-3-Methyl-7-(phenylMethyl)-1H-purine-2,6-dione | | Synonyms: | 8-BroMo-3,7-dihydro-3-Methyl-7-(phenylMethyl)-1H-purine-2,6-dione;7-benzyl-8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione;7-Benzyl-8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione;1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-7-(phenylmethyl)- | | CAS: | 93703-26-5 | | MF: | C13H11BrN4O2 | | MW: | 335.16 | | EINECS: | | | Product Categories: | Aromatics, Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals | | Mol File: | 93703-26-5.mol |  |
| | 8-BroMo-3,7-dihydro-3-Methyl-7-(phenylMethyl)-1H-purine-2,6-dione Chemical Properties |
| density | 1.73±0.1 g/cm3(Predicted) | | pka | 9.06±0.70(Predicted) |
| | 8-BroMo-3,7-dihydro-3-Methyl-7-(phenylMethyl)-1H-purine-2,6-dione Usage And Synthesis |
| Uses | 8-Bromo-3,7-dihydro-3-methyl-7-(phenylmethyl)-1H-purine-2,6-dione,is a substituted derivative of of Xanthine (X499950), found in animal organs, yeast, potatoes, coffee beans, tea. It can also be used for the synthesis of Linagliptin (L465900), which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
| | 8-BroMo-3,7-dihydro-3-Methyl-7-(phenylMethyl)-1H-purine-2,6-dione Preparation Products And Raw materials |
|